The human glomerular podocyte is a novel target for insulin action

被引:237
作者
Coward, RJM
Welsh, GI
Yang, J
Tasman, C
Lennon, R
Koziell, A
Satchell, S
Holman, GD
Kerjaschki, D
Tavaré, JM
Mathieson, PW
Saleem, MA
机构
[1] Univ Bristol, Dept Biochem, Bristol, Avon, England
[2] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[3] UCL, Mol Med Unit, Inst Child Hlth, London, England
[4] Univ Vienna, Dept Clin Pathol, Vienna, Austria
基金
英国惠康基金;
关键词
D O I
10.2337/diabetes.54.11.3095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microalbuminuria is significant both as the earliest stage of diabetic nephropathy and as an independent cardiovascular risk factor in nondiabetic subjects, in whom it is associated with insulin resistance. The link between disorders of cellular insulin metabolism and albuminuria has been elusive. Here, we report using novel conditionally immortalized human podocytes in vitro and human glomeruli ex vivo that the podocyte, the principal cell responsible for prevention of urinary protein loss, is insulin responsive and able to approximately double its glucose uptake within 15 min of insulin stimulation. Conditionally immortalized human glomerular endothelial cells do not respond to insulin, suggesting that insulin has a specific effect on the podocyte in the glomerular filtration barrier. The insulin response of the podocyte occurs via the facilitative glucose transporters GLUT1 and GLUT4, and this process is dependent on the filamentous actin cytoskeleton. Insulin responsiveness in this key structural component of the glomerular filtration barrier may have central relevance for understanding of diabetic nephropathy and for the association of albuminuria with states of insulin resistance.
引用
收藏
页码:3095 / 3102
页数:8
相关论文
共 37 条
[1]   GLOMERULAR EPITHELIAL FOOT PROCESSES AND FILTRATION SLITS IN IDDM PATIENTS [J].
BJORN, SF ;
BANGSTAD, HJ ;
HANSSEN, KF ;
NYBERG, G ;
WALKER, JD ;
VIBERTI, GC ;
OSTERBY, R .
DIABETOLOGIA, 1995, 38 (10) :1197-1204
[2]   NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome [J].
Boute, N ;
Gribouval, O ;
Roselli, S ;
Benessy, F ;
Lee, H ;
Fuchshuber, A ;
Dahan, K ;
Gubler, MC ;
Niaudet, P ;
Antignac, C .
NATURE GENETICS, 2000, 24 (04) :349-354
[3]   INSULIN-RESPONSIVE GLUCOSE TRANSPORTER EXPRESSION IN RENAL MICROVESSELS AND GLOMERULI [J].
BROSIUS, FC ;
BRIGGS, JP ;
MARCUS, RG ;
BARACNIETO, M ;
CHARRON, MJ .
KIDNEY INTERNATIONAL, 1992, 42 (05) :1086-1092
[4]  
CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800
[5]   ANATOMICAL AND DEVELOPMENTAL PATTERNS OF FACILITATIVE GLUCOSE TRANSPORTER GENE-EXPRESSION IN THE RAT-KIDNEY [J].
CHIN, E ;
ZHOU, J ;
BONDY, C .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1810-1815
[6]   Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes [J].
Dalla Vestra, M ;
Masiero, A ;
Roiter, AM ;
Saller, A ;
Crepaldi, G ;
Fioretto, P .
DIABETES, 2003, 52 (04) :1031-1035
[7]   Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes - Evidence of the existence of different intracellular GLUT4 vesicle populations [J].
Fischer, Y ;
Thomas, J ;
Sevilla, L ;
Munoz, P ;
Becker, C ;
Holman, G ;
Kozka, IJ ;
Palacin, M ;
Testar, X ;
Kammermeier, H ;
Zorzano, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :7085-7092
[8]  
GORDON JA, 1991, METHOD ENZYMOL, V201, P477
[9]  
HEILIG C, 1995, LAB INVEST, V73, P674
[10]  
HOLMAN GD, 1990, J BIOL CHEM, V265, P18172